Prognostic Value of the Objective Measurement of Daily Physical Activity in Patients with COPD
Overview
Authors
Affiliations
Background: Subjective measurement of physical activity using questionnaires has prognostic value in COPD. However, their lack of accuracy and large individual variability limit their use for evaluation on an individual basis. We evaluated the capacity of the objective measurement of daily physical activity in patients with COPD using accelerometers to estimate their prognostic value.
Methods: In 173 consecutive subjects with moderate to very severe COPD, daily physical activity was measured using a triaxial accelerometer providing a mean of 1-min movement epochs as vector magnitude units (VMUs). Patients were evaluated by lung function testing and 6-min walk, incremental exercise, and constant work rate tests. Patients were followed for 5 to 8 years, and the end points were all-cause mortality, hospitalization for COPD exacerbation, and annual declining FEV(1).
Results: After adjusting for relevant confounders, a high VMU decreased the mortality risk (adjusted hazard ratio [HR], 0.986; 95% CI, 0.981-0.992), and in a multivariate model, comorbidity, endurance time, and VMU were retained as independent predictors of mortality. The time until first admission due to COPD exacerbation was shorter for the patients with lower levels of VMU (adjusted HR, 0.989; 95% CI, 0.983-0.995). Moreover, patients with higher VMU had a lower hospitalization risk than those with a low VMU (adjusted incidence rate ratio, 0.099; 95% CI, 0.033-0.293). In contrast, VMU was not identified as an independent predictor of the annual FEV(1) decline.
Conclusion: The objective measurement of the daily physical activity in patients with COPD using an accelerometer constitutes an independent prognostic factor for mortality and hospitalization due to severe exacerbation.
Valeiro B, Rodriguez E, Ferrer J, Pasarin A, Ibanez J, Ramon M ERJ Open Res. 2025; 11(1.
PMID: 39811552 PMC: 11726703. DOI: 10.1183/23120541.00216-2024.
The impact of body mass index on mortality in COPD: an updated dose-response meta-analysis.
Tenda E, Henrina J, Setiadharma A, Felix I, Yulianti M, Pitoyo C Eur Respir Rev. 2024; 33(174).
PMID: 39603663 PMC: 11600125. DOI: 10.1183/16000617.0261-2023.
Clinical review of non-invasive ventilation.
Criner G, Gayen S, Zantah M, Dominguez Castillo E, Naranjo M, Lashari B Eur Respir J. 2024; 64(5).
PMID: 39227076 PMC: 11540995. DOI: 10.1183/13993003.00396-2024.
Popham S, Burq M, Rainaldi E, Shin S, Dunn J, Kapur R JMIR Biomed Eng. 2024; 8:e43726.
PMID: 38875664 PMC: 11041455. DOI: 10.2196/43726.
The importance of addressing physical activity and exercise intolerance in our patients with COPD.
Goldstein R, Jardim J, Nici L, Raskin J, Spruit M, ZuWallack R Breathe (Sheff). 2024; 20(2):230272.
PMID: 38873238 PMC: 11167653. DOI: 10.1183/20734735.0272-2023.